CHF72.90
CHF0.00 (0.00%)
End-of-day quote: 05/17/2024
SWX:COPN
Cosmo Pharmaceuticals N.V. Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| ARGX | argenx | ENXTBR | Outperform | 339.90€ | 531.81€ | 0.00% | 10 | 20.20€B |
| GMAB | Genmab A/S | CPSE | Outperform | kr2.04k | kr2.71k | 0.00% | 14 | kr131.83B |
| REC | Recordati Industria Chimica e ... | BIT | Hold | 51.20€ | 48.61€ | 0.00% | 1 | 10.36€B |
| ZEAL | Zealand Pharma A/S | CPSE | Buy | kr600.00 | kr357.00 | 0.00% | 2 | kr38.52B |
| HIK | Hikma Pharmaceuticals PLC | LSE | Outperform | £19.78 | £28.11 | 0.00% | 9 | £4.42B |
| ORNBV | Orion Oyj | HLSE | Hold | 37.69€ | 42.52€ | 0.00% | 3 | 5.12€B |
| ALK B | ALK-Abelló A/S | CPSE | Outperform | kr152.00 | kr109.25 | 0.00% | 3 | kr33.91B |
| ALKS | Alkermes | NasdaqGS | Outperform | $24.15 | $33.27 | 0.00% | 3 | $4.11B |
| MOR | MorphoSys | XTRA | Hold | 69.35€ | 28.78€ | 0.00% | 3 | 2.52€B |
| INDV | Indivior PLC | LSE | Buy | £13.37 | £28.89 | 0.00% | 4 | £1.95B |
| ALM | Almirall | BME | Outperform | 9.27€ | 11.39€ | 0.00% | 3 | 1.94€B |
| EVT | Evotec | XTRA | Outperform | 9.76€ | 37.33€ | 0.00% | 4 | 1.73€B |
| SUPN | Supernus Pharmaceuticals | NasdaqGM | Outperform | $29.10 | $41.00 | 0.00% | 0 | $1.72B |
| FAE | Faes Farma | BME | Hold | 3.66€ | 3.90€ | 0.00% | 0 | 1.09€B |
| PHM | Pharma Mar | BME | Outperform | 36.72€ | 50.20€ | 0.00% | 1 | 536.95€M |
| BSLN | Basilea Pharmaceutica | SWX | Outperform | CHF43.65 | CHF65.63 | 0.00% | 0 | CHF529.94M |
| DBV | DBV Technologies | ENXTPA | Outperform | 1.27€ | 4.07€ | 0.00% | 1 | 115.65€M |
| MOLN | Molecular Partners | SWX | Outperform | CHF3.31 | CHF9.50 | 0.00% | 1 | CHF110.77M |
| ASRT | Assertio Holdings | NasdaqCM | Buy | $1.07 | $3.50 | 0.00% | 2 | $100.36M |
| DRRX | DURECT | NasdaqCM | Outperform | $0.93 | $6.75 | 0.00% | 2 | $33.21M |
